Greenwood M R, Cleary M P, Gruen R, Blase D, Stern J S, Triscari J, Sullivan A C
Am J Physiol. 1981 Jan;240(1):E72-8. doi: 10.1152/ajpendo.1981.240.1.E72.
Young Zucker lean (Fa/-) and obese (fa/fa) female rats were fed the fatty acid synthesis inhibitor (-)-hydroxy-citrate as a dietary admixture for 39 days. In the lean rats, (-)-hydroxycitrate treatment decreased body weight, food intake, percent of body fat, and fat cell size. In the obese rat, food intake and body weight were reduced but the percent of body fat remained unchanged. Throughout the treatment period, obese rats maintained a fat cell size equivalent to their obese controls. Although a reduction in fat cell number in the obese rats occurred during the treatment period, marked hyperplasia was observed during the posttreatment period. The results of this study indicate that the obese rat, despite a substantial reduction in body weight produced by (-)-hydroxycitrate, still defends its obese body composition.
将年轻的 Zucker 瘦型(Fa/-)和肥胖型(fa/fa)雌性大鼠作为饮食添加剂喂食脂肪酸合成抑制剂(-)-羟基柠檬酸 39 天。在瘦型大鼠中,(-)-羟基柠檬酸处理降低了体重、食物摄入量、体脂百分比和脂肪细胞大小。在肥胖大鼠中,食物摄入量和体重降低,但体脂百分比保持不变。在整个治疗期间,肥胖大鼠的脂肪细胞大小与肥胖对照组相当。尽管在治疗期间肥胖大鼠的脂肪细胞数量减少,但在治疗后观察到明显的增生。本研究结果表明,肥胖大鼠尽管因(-)-羟基柠檬酸导致体重大幅降低,但仍维持其肥胖的身体组成。